Skip to content
IP + Technology Law
Home  »  News & Insights  »  News

Partners Eli Loots, Ph.D. and Mike Fuller Discuss “Authorised Biosimilars” in BioPharm Insight

March 3, 2016  | Michael L. Fuller

Partners Eli Loots, Ph.D. and Mike Fuller were interviewed for the article “Biosimilars could follow route of authorised generics though technical, market hurdles draw timeline uncertainty” in BioPharm Insight. 

Read the full article on the BioPharm Insight website >> (Subscription required)

Partners Eli Loots, Ph.D. and Mike Fuller Discuss “Authorised Biosimilars” in BioPharm Insight Headshot

Michael L. Fuller
Partner
San Diego
mike.fuller@knobbe.com
858-707-4000

Related Links

Industries

News & Insights

Publications
Jan 2026
Knobbe Martens Partners Jeremiah Helm and Sean Murray Analyze Federal Circuit’s “Blaze Marks” Guidance in Law360
In their latest Law360 column on the Federal Circuit’s recent notable rulings, Knobbe Martens partners Jeremiah Helm and Sean Murray explore the court’s decision in Duke University v. Sandoz, a...
News
Jan 2026
Knobbe Martens Again Receives Top Recognition in World Trademark Review 1000 Guide
IRVINE, Calif., January 30, 2026 – Knobbe Martens is pleased to share that the firm’s Trademark and Brand Protection practice and ten of its partners have once again been recognized...
News
Jan 2026
Knobbe Martens Recognized for Standout Trade Secrets Work in World IP Review USA Rankings
Firm, partners featured in guide for success in trade secret litigation matters IRVINE, Calif., January 28, 2026 – Knobbe Martens is proud to share that the firm and its partners...